miR-145 suppresses thyroid cancer growth and metastasis and targets AKT3

Myriem Boufraqech(National Cancer Institute), Electron Kebebew(Stanford University)
Endocrine Related Cancer
April 29, 2014
10.1530/erc-14-0077
Cited by 109

Related Papers

2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
|Thyroid|2021|699
MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets
|Endocrine Related Cancer|2010|84
MiR-20a Is Upregulated in Anaplastic Thyroid Cancer and Targets LIMK1
|PLoS ONE|2014|61
Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer
|Oncotarget|2015|58
miR-126-3p Inhibits Thyroid Cancer Cell Growth and Metastasis, and Is Associated with Aggressive Thyroid Cancer
|PLoS ONE|2015|57